Wolverine Trading’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$219K	Sell	8,486 -35,333	-81%	-$1.05M	﹤0.01%	4815
2025 Q2	$1.16M	Sell	43,819 -20,276	-32%	-$534K	﹤0.01%	2168
2025 Q1	$1.64M	Buy	64,095 +16,327	+34%	+$516K	﹤0.01%	1782
2024 Q4	$1.9M	Sell	47,768 -7,743	-14%	-$442K	﹤0.01%	2012
2024 Q3	$3.42M	Buy	55,511 +37,462	+208%	+$2.2M	﹤0.01%	1306
2024 Q2	$957K	Sell	18,049 -2,925	-14%	-$192K	﹤0.01%	2216
2024 Q1	$1.72M	Buy	20,974 +9,788	+88%	+$436K	﹤0.01%	1724
2023 Q4	$208K	Sell	11,186 -28,237	-72%	-$369K	﹤0.01%	3833
2023 Q3	$436K	Sell	39,423 -112,383	-74%	-$1.61M	﹤0.01%	2896
2023 Q2	$2.37M	Sell	151,806 -12,457	-8%	-$261K	﹤0.01%	1383
2023 Q1	$2.85M	Buy	164,263 +128,120	+354%	+$1.32M	﹤0.01%	1152
2022 Q4	$340K	Buy	+36,143	New	+$161K	﹤0.01%	2660
2022 Q1	–	Sell	-16,250	Closed	-$58.3K	–	6538
2021 Q4	$75K	Buy	+16,250	New	+$91.1K	﹤0.01%	5198
2020 Q2	–	Sell	-30,615	Closed	-$203K	–	5293
2020 Q1	$145K	Buy	+30,615	New	+$188K	﹤0.01%	3846
2019 Q1	–	Sell	-41,774	Closed	-$316K	–	5378
2018 Q4	$316K	Sell	41,774 -26,436	-39%	-$316K	﹤0.01%	3127
2018 Q3	$1.19M	Buy	+68,210	New	+$812K	﹤0.01%	2160